Melatonin protects against endometriosis via regulation of matrix metalloproteinase-3 and an apoptotic pathway

Journal of Pineal Research

Volumn 49, Issue 2, 2010, Pages 156-168

  Paul, Sumit ^a   Bhattacharya, Partha ^b   Mahapatra, Pramathes Das ^b   Swarnakar, Snehasikta ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b Spectrum Clinic and Endoscopy Research Institute   (India)

Author keywords

apoptosis; endometriosis; inflammation; matrix metalloproteinase 3; melatonin; tissue inhibitor of metalloproteinase 3

Indexed keywords

CASPASE 9; GELATINASE B; MELATONIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN C FOS; STROMELYSIN; TRANSCRIPTION FACTOR AP 1; UROKINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MECHANISM; ENDOMETRIOSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; FEMALE; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PROTEIN DNA BINDING; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; ENDOMETRIOSIS; ENDOMETRIUM; EPITHELIUM; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MELATONIN; MICE; MICE, INBRED BALB C; PROTO-ONCOGENE PROTEINS C-FOS; SIGNAL TRANSDUCTION; SWINE; TISSUE INHIBITOR OF METALLOPROTEINASE-3; UP-REGULATION; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 77955153298     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2010.00780.x     Document Type: Article

References (62)

1. Somigliana E, Vigano P, Vignali M. Endometriosis and unexplained recurrent spontaneous abortion: pathological states resulting from aberrant modulation of natural killer cell function? Hum Reprod Update 1999 5 : 40 51.
2. Modugno F, Ness RB, Allen GO et al. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis. Am J Obstet Gynecol 2004 191 : 733 740.
3. Spuijbroek MD, Dunselman GA, Menheere PP et al. Early endometriosis invades the extracellular matrix. Fertil Steril 1992 58 : 929 933.
4. Giudice LC, Tazuke SI, Swiersz L. Status of current research on endometriosis. J Reprod Med 1998 43 : 252 262.
5. Sampson J. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 1927 14 : 422 469.
6. Bruner KL, Matrisian LM, Rodgers WH et al. Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. J Clin Invest 1997 99 : 2851 2857.
7. Cosin R, Gilabert-Estelles J, Ramon LA et al. Influence of peritoneal fluid on the expression of angiogenic and proteolytic factors in cultures of endometrial cells from women with endometriosis. Hum Reprod 2010 25 : 398 405.
8. Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 1990 6 : 121 125.
9. Higuchi T, Kanzaki H, Nakayama H et al. Induction of tissue inhibitor of metalloproteinase 3 gene expression during in vitro decidualization of human endometrial stromal cells. Endocrinology 1995 136 : 4973 4981.
10. Woessner JF Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991 5 : 2145 2154.
11. Radisky DC, Levy DD, Littlepage LE et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 2005 436 : 123 127.
12. Maatta M, Soini Y, Liakka A et al. Localization of MT1-MMP, TIMP-1, TIMP-2, and TIMP-3 messenger RNA in normal, hyperplastic, and neoplastic endometrium. Enhanced expression by endometrial adenocarcinomas is associated with low differentiation. Am J Clin Pathol 2000 114 : 402 411.
13. Kokorine I, Nisolle M, Donnez J et al. Expression of interstitial collagenase (matrix metalloproteinase-1) is related to the activity of human endometriotic lesions. Fertil Steril 1997 68 : 246 251.
14. Chung HW, Lee JY, Moon HS et al. Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium. Fertil Steril 2002 78 : 787 795.
15. Cox KE, Piva M, Sharpe-Timms KL. Differential regulation of matrix metalloproteinase-3 gene expression in endometriotic lesions compared with endometrium. Biol Reprod 2001 65 : 1297 1303.
16. Igarashi TM, Bruner-Tran KL, Yeaman GR et al. Reduced expression of progesterone receptor-B in the endometrium of women with endometriosis and in cocultures of endometrial cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fertil Steril 2005 84 : 67 74.
17. Collette T, Bellehumeur C, Kats R et al. Evidence for an increased release of proteolytic activity by the eutopic endometrial tissue in women with endometriosis and for involvement of matrix metalloproteinase-9. Hum Reprod 2004 19 : 1257 1264.
18. Paul S, Sharma AV, Mahapatra PD et al. Role of melatonin in regulating matrix metalloproteinase-9 via tissue inhibitors of metalloproteinase-1 during protection against endometriosis. J Pineal Res 2008 44 : 439 449. Epub 2008 Feb 19.
19. Ogata Y, Enghild JJ, Nagase H. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem 1992 267 : 3581 3584.
20. Knauper V, Wilhelm SM, Seperack PK et al. Direct activation of human neutrophil procollagenase by recombinant stromelysin. Biochem J 1993 295 : 581 586.
21. Ramos-Desimone N, Hahn-Dantona E, Sipley J et al. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J Biol Chem 1999 274 : 13066 13076.
22. D'Souza CA, Mak B, Moscarello MA The up-regulation of stromelysin-1 (MMP-3) in a spontaneously demyelinating transgenic mouse precedes onset of disease. J Biol Chem 2002 277 : 13589 13596. Epub 2002 Feb 5.
23. Vernon MW, Wilson EA. Studies on the surgical induction of endometriosis in the rat. Fertil Steril 1985 44 : 684 694.
24. Pinkus R, Weiner LM, Daniel V. Role of oxidants and antioxidants in the induction of AP-1, NF-kappaB, and glutathione S-transferase gene expression. J Biol Chem 1996 271 : 13422 13429.
25. Schenk H, Klein M, Erdbrugger W et al. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1. Proc Natl Acad Sci U S A 1994 91 : 1672 1676.
26. Benbow U, Brinckerhoff CE. The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol 1997 15 : 519 526.
27. Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991 1072 : 129 157.
28. Kirkland JL, Murthy L, Stancel GM. Progesterone inhibits the estrogen-induced expression of c-fos messenger ribonucleic acid in the uterus. Endocrinology 1992 130 : 3223 3230.
29. Hastings JM, Jackson KS, Mavrogianis PA et al. The estrogen early response gene FOS is altered in a baboon model of endometriosis. Biol Reprod 2006 75 : 176 182.
30. Morsch DM, Carneiro MM, Lecke SB et al. c-fos gene and protein expression in pelvic endometriosis: a local marker of estrogen action. J Mol Histol 2009 40 : 53 58.
31. Redman J, Armstrong S. NG KT Free-running activity rhythms in the rat: entrainment by melatonin. Science 1983 219 : 1089 1091.
32. Reiter RJ, Tan DX, Manchester LC et al. Melatonin and reproduction revisited. Biol Reprod 2009 81 : 445 456.
33. Maldonado MD, Murillo-Cabezas F, Terron MP et al. The potential of melatonin in reducing morbidity-mortality after craniocerebral trauma. J Pineal Res 2007 42 : 1 11.
34. Guney M, Oral B, Karahan N et al. Regression of endometrial explants in a rat model of endometriosis treated with melatonin. Fertil Steril 2008 89 : 934 942.
35. Hardeland R. Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine 2005 27 : 119 130.
36. Peyrot F, Ducrocq C. Potential role of tryptophan derivatives in stress responses characterized by the generation of reactive oxygen and nitrogen species. J Pineal Res 2008 45 : 235 246.
37. Garcia-Santos G, Antolin I, Herrera F et al. Melatonin induces apoptosis in human neuroblastoma cancer cells. J Pineal Res 2006 41 : 130 135.
38. Martin-Renedo J, Mauriz JL, Jorquera F et al. Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line. J Pineal Res 2008 45 : 532 540.
39. Salvesen GS, Riedl SJ. Caspase Mechanisms. Adv Exp Med Biol, 2008 615 : 13 23.
40. Reed JC. Mechanisms of apoptosis. Am J Pathol 2000 157 : 1415 1430.
41. Rock JA. The revised American Fertility Society classification of endometriosis: reproducibility of scoring. ZOLADEX Endometriosis Study Group. Fertil Steril 1995 63 : 1108 1110.
42. Lowry OH, Rosebrough NJ, Farr AL et al. Protein measurement with the Folin phenol reagent. J Biol Chem 1951 193 : 265 275.
43. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976 72 : 248 254.
44. Kundu P, Mukhopadhyay AK, Patra R et al. Cag pathogenicity island-independent up-regulation of matrix metalloproteinases-9 and -2 secretion and expression in mice by Helicobacter pylori infection. J Biol Chem 2006 281 : 34651 34662. Epub 2006 Sep 11.
45. Snoek-Van Beurden PA, Von Den Hoff JW. Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors. BioTechniques 2005 38 : 73 83.
46. Chaturvedi MM, Mukhopadhyay A, Aggarwal BB. Assay for redox-sensitive transcription factor. Methods Enzymol 2000 319 : 585 602.
47. Black RA. TIMP3 checks inflammation. Nat Genet 2004 36 : 934 935.
48. Ahonen M, Poukkula M, Baker AH et al. Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors. Oncogene 2003 22 : 2121 2134.
49. Baker AH, Zaltsman AB, George SJ et al. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. J Clin Invest 1998 101 : 1478 1487.
50. Bond M, Murphy G, Bennett MR et al. Tissue inhibitor of metalloproteinase-3 induces a Fas-associated death domain-dependent Type II apoptotic pathway. J Biol Chem 2002 277 : 13787 13795.
51. Gilabert-Estelles J, Estelles A, Gilabert J et al. Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis. Hum Reprod 2003 18 : 1516 1522.
52. Eisermann J, Gast MJ, Pineda J et al. Tumor necrosis factor in peritoneal fluid of women undergoing laparoscopic surgery. Fertil Steril 1988 50 : 573 579.
53. Grund EM, Kagan D, Tran CA et al. Tumor necrosis factor-α regulates inflammatory and mesenchymal responses via mitogen-activated protein kinase kinase, p38, and nuclear factor IκB in human endometriotic epithelial cells. Mol Pharmacol 2008 73 : 1394 1404.
54. Andrea GB, Romana AN. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer. Am J Reprod Immunol 2006 56 : 201 214.
55. D'Antonio M, Martelli F, Peano S et al. Ability of recombinant human TNF binding protein-1 (r-hTBP-1) to inhibit the development of experimentally- induced endometriosis in rats. J Reprod Immunol 2000 48 : 81 98.
56. Pugsley MK. Etanercept. Immunex. Curr Opin Investig Drugs 2001 2 : 1725 1731.
57. Monckedieck V, Sannecke C, Husen B et al. Progestins inhibit expression of MMPs and of angiogenic factors in human ectopic endometrial lesions in a mouse model. Mol Hum Reprod 2009 15 : 633 643.
58. Akkaya P, Onalan G, Haberal N et al. Doxycycline causes regression of endometriotic implants: a rat model. Hum Reprod 2009 24 : 1900 1908.
59. Tamarkin L, Cohen M, Roselle D et al. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat. Cancer Res 1981 41 : 4432 4436.
60. Lissoni P, Chilelli M, Villa S et al. Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial. J Pineal Res 2003 35 : 12 15.
61. Treeck O, Haldar C, Ortmann O. Antiestrogens modulate MT1 melatonin receptor expression in breast and ovarian cancer cell lines. Oncol Rep 2006 15 : 231 235.
62. Oztekin E, Mogulkoc R, Baltaci AK et al. The influence of estradiol and progesterone and melatonin supplementation on TNF-alpha levels in ovariectomized and pinealectomized rats. Acta Biol Hung 2006 57 : 275 281.